A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.